Posted on



For many years since the prohibition, cannabis has been considered a control drug by state entities and cataloged as a public health problem for society, for which it has not had good eyes when it comes to regulating, to combat in turn, the illicit market that is present and latent in each nation, and is controlled by organizations outside the law that even cross many borders.

Colombia has not been immune to this situation and for a long time since the war, it has had the stigma of being among the countries with the highest illegal cannabis production, being the world pantry for recreational cannabis. However, in recent months a green wave or race has been forming in the European powers to position or categorize cannabis outside of the strongest drugs with which it has always been compared; which has made countries such as Germany, Malta, the Czech Republic, the Netherlands, Switzerland and Luxembourg, look for the best possible way to regulate the adult use market and thus combat the figures of the black market, while offering consumers safe and informed access to quality cannabis from a trusted source.

Undoubtedly, this career cannot be done in a hurry and takes all the administrative and legal time that corresponds to a change in national regulations and its regulation, where it is explained how issues such as cultivation, dispensing, maximum limits, taxes and fees, prohibitions, size and consumption, there are many pillars that must be taken into account to carry out a satisfactory transition towards the release of the plant.

Although it is true that first experience speaks of the regulation of medicinal cannabis, some countries have considered adult use first on their agendas and later medicinal use, due to the greater regulatory conditions that this opening entails, only from 2020 to By 2025, growth of 24% per year is expected, and this figure will be higher as more countries join this green wave.

Posted on


Adriana Herrera


thebussinesslyear COLOMBIA 2022/23

EHCOL has pioneered uniquely Colombian strains of medical cannabis on its journey to offer added value across the supply chain.

How do EHCOL’s cannabis strains, Colombian Splrit and Colomblan Angel, add value for partners across the supply chain? How can world-class genetics unlock potential for growers transform the   business?

EHCOL has been strategically focused from the beginning on developing pre­mium quality for industry allies by having a product portfolio with world class genetics under the guidance of our partners, which have ranked among the pioneers of the cannabis market in the US for nine years. Our first CBD genetics, Colombian Spirit and Colombian Angel, as well as recently registered Colombian Calm and Colombian Emerald. are the result of a demanding selection of phenotypes each with their own outstanding characteristics? These include high CBD potency, low THC levels, unique terpenes profile, high yields in the production of dry flower, and pest and diseases resistance. EHCOL’s goal has not only been high standard quality but also creating tide-up relations from firs1 contact stablish long- term relationships

by providing a true-factor solution. Wi1h EHCOL. our partners add value to their supply chain as they increase their productivity and reach maximum effectiveness by using our certified homogeneous genetics with potencies up of 28% of CBD and less than 1% of THC. This allows growers tto develop crops with high resistance to climatic conditions, pests, diseases, high yield in production and lower processing costs by efficiency. In addition, with the high power of our different strains of   CBD,CBG, and THC, we are able to supply smokable dry flower or the highest quality ,which is the most consumed  and  prescribed  part  of the

plant in the medical cannabis markets around the world.

What does EHCOL focus on its efforts to become the leading local supplier of cannabis inputs?

Our business model is aimed at the B2B level of the global cannabis industry, offering added value to the supply chain of this huge market. Our competitive advantage is based on being able to offer a seed bank and a portfolio of dried flowers with high cannabinoid potency, added to the advantages of Colombia’s climatic and geographical conditions and low-cost production. To accomplish this, we make sure to develop only prime genetics, an essential component to achieve high-quality results. With the outstanding results of our current genetics, we are ready to supply homogeneous feminized seeds for growers as well as CBD, CBG, and THC dry flower globally for medicinal and pharmaceutical purposes.

What community welfare and shared prosperity campaigns does Earth’s Healing incorporate across the value chain

Our company is located near Santander

de Quilichao, a community that has historically suffered from the armed conflict. We offer formal employment to its inhabitants, especially the local women, who are mostly heads of households. Likewise, we participate in the area’s economic growth, as several of our suppliers are in the surrounding 1owns. Our goal as a company includes providing support to meet the most pressing needs of the village through the community action board. In the same way, we are

structuring support for small producers in the region by offering technical training, to give them tools that will help them improve their cultivation processes.

How Is the cannabis business projected to?

evolve in the medium and long term, how is EHCOL looking to capitalize on opportunities such as cannabis in food and beverages and adult use?

Thanks to the wide variety of cannabinoids present in cannabis plants and

the research advances to find medicinal properties as a treatment for diseases and for well-being, this industry has immense opportunities, many of them yet to be explored. And although we are open to partnerships with the growing food and beverage industry, our business model is oriented to seeds for cultivation and smokable dry flower for medicinal purposes. With our superior quality genetics. we will play an important role worldwide in the consumption of cannabis for adult use. and for pharmaceutical purposes. We will continue to develop genetics that add value to medicinal solutions and improve the life quality of the patient. Therefore, our purpose since the outset has been to: Harvest harmony, cultivated from the best cannabis.

Posted on

Trichomes and the cannabis plant.

Cannabis flower is usually consumed for its medicinal properties that provide relaxing and calming effects. It is also prescribed today to help with a range of medical conditions including chronic pain, glaucoma and lack of appetite.
Worldwide, the dried flower is the best-selling product, among other reasons because consuming the cannabinoids and terpenes at the same time enhances its medicinal effect. It is in the flower and its “sugar Leaves” that the vast majority of trichome glands are found.
Cannabis plants contain more than 400 different chemical compounds, or cannabinoids, each of which has its own distinctive and structural properties. Terpenes have aromatic properties, flavor and aroma, and many also have pharmacological properties, such as antiseptic and anti-inflammatory effects.
The production of cannabinoids and their terpenes in cannabis plants is subject to the influence of environmental factors, as well as hereditary factors. Their biosynthesis occurs in specialized glands that develop throughout the aerial structure of the plant and serve as a defensive agent against pests and UV filter.
These small bulbous glands rich in resins that grow in the flowers and leaves of the cannabis plant are the real factory of terpenes and cannabinoids with superior therapeutic properties for human health and well-being.
Researchers from the College of Agriculture, Health and Natural Resources of Connecticut in the United States discovered the genetic mechanism by which the plant produces glandular trichomes to protect the flowers against a wide variety of pests during their flowering period.
What does this discovery bring to the cannabis industry? Identifying how trichomes are naturally generated offers the possibility of developing a technological mechanism to produce terpenes and cannabinoids. And at the same time, to inhibit this process if necessary for some industrial objective with the plant. With the first option, a leap could be made in the production of active compounds from the plant. With the second, it would be possible to guarantee varieties with low cannabinoid content that focus their production on fiber and flowers without trichomes. Knowing how cannabis produces trichomes opens two important scenarios for the industry. On the one hand, to be able to develop plants with high production of active cannabinoids such as THC, CBD, CBG and CBN, with a high medicinal grade; it would also allow, if desired, to cultivate plants focused on the production of fiber, something key for the hemp industry and its derivatives.
This discovery is a breakthrough for the global cannabis industry, as the plant still has many stigmas and restrictions worldwide. A specific case is the cultivation of hemp, for example, there are threshold limits of psychoactive cannabinoids such as THC established by law, something that plants are clearly unaware of and often exceed, this often forces to discard entire crops of hemp, with consequent large economic losses for companies.
On the other hand, in the not so distant future it is expected that this new technology can be applied in another sense, producing cannabis varieties that generate even more trichomes without having to appeal to long processes of natural selection and without the risk of losses due to worldwide restrictions on the use of cannabis in any country.
It would simply be a matter of choosing a variety with a desired cannabinoid profile. Psychoactive or non-psychoactive and through artificial stimulation of a natural process, multiply the production of trichomes and in turn of medicinal substances and legal or regulated by the country in which it is grown and to which it is intended to be exported. This will make the industry advance by leaps and bounds.
It is worth noting that for a successful development of medicinal trichomes, it is very important the luminosity given to the plants, their nutrients and a harvest at the right time in which the heads of the trichomes show a coloration with a percentage of approximately 60% “milky” color, percentages of amber and clear color of approximately 20% each. Likewise, it is necessary to take care of the trichomes in their drying, trimming and curing process so that the dried flower reaches the hands of the patients preserving the great majority of cannabinoids and terpenes.


Posted on

Superior Quality

Adriana Herrera is a business administrator specializing in senior management. She has over 30 years of experience working as manager of different companies in the public, private, and union sectors of the region, among others. She is the co-founder of Earth’s Healing Colombia, a company in which she serves as CEO.

The Business Year 2022-Interview.

With its superior quality genetics, Earth’s Healing Colombia plays an important role in adding value to medicinal solutions and improving the quality of life of patients.

Earth's Healing Colombia

How do EHCOL’s cannabis strains add value for partners across the sup- ply chain?

EHCOL has been strategically focused from the beginning on get- ting a premium quality for the industry allies by having a prod- uct portfolio with world-class genetics under the guidance of our partners, who have ranked among the pioneers of the cannabis market in US for nine years. Our CBD genetics Colombian Spirit and Colombian Angel, as well as recently registered Colombian Calm and Colombian Emerald, are the result of a demanding se- lection of phenotypes each with their own characteristics. These include a high potency of CBD, low THC level, a unique ter- penes profile, high yield in production of dried flower, and pest and diseases resistance. EHCOL’s goal has been not only a high standard quality but also establishing long-term relationships by understanding what clients really need and providing a true-fac- tor solution. With EHCOL, our partners add value to their supply chains. They increase their productivity and reach maximum effectiveness by using our certified homogeneous genetics with potency up to 28% of CBD and less than 1% of THC. This allows growers to develop crops with high resistance to climatic condi- tions, pests, and diseases, as well as produce high yields at lower processing costs. In addition, with the high power of CBD, we are able to supply plant material with THC below 0.2%, keeping its non-psychoactive trait in each country.

What does Earth’s Healing focus on in its efforts to become the leading local supplier of cannabis inputs?

Our business model is aimed at the B2B market of the global can- nabis industry, offering unique and personalized experiences for new and actual customers. Our competitive advantage is based on being able to offer a bank of seeds and a portfolio of dried flowers with high cannabinoid potency, making deep and lasting relationships. To do this, we make sure to include only world-class genetics, an essential component to achieving high-quality results. With the outstanding results of our current genetics, we are ready to supply homogeneous feminized seeds for growers as well as CBD and CBG flower globally for medicinal and industrial purposes.

What characterizes the company’s approach to agro-science, and what innovative process does EHCOL realize in offering tailor-made service to its partners?

From 75 genetics pre-registered with the Colombian govern- ment, we have six of our own brands of cultivars already duly reg- istered with the national government and available to our allies, four of them are CBD and two of CBG. Currently, we are working on an agronomic evaluation of five new strains with high THC potency. For each of our genetics already registered, and those we are evaluating, we have fully standardized processes and a continuous improvement program that guarantee consistency. The objective is for our allies to find products of superior qual- ity, totally homogenized, and 100% organic flowers in EHCOL’s portfolio and be assured of receiving a product through clear and transparent operations.

What sectors of the industry offer the best potential for collaboration and how do certifications such as GACP and GMP expand the pool of oppor- tunities?

At EHCOL, we hold BPA certification from the ICA and have com- pleted the GACP certification from ICONTEC. This allows us to guarantee the market that it is acquiring products of high quality and consistency. These certifications demonstrate that we work to protect the environment, that we care about the wellbeing of our employees, and that we have safe and high-quality process- es. At EHCOL, we have been working strategically to standard- ize and improve our processes to develop globally competitive products. The greatest importance for EHCOL of having BPA and GACP certification is to be able to guarantee a clean, safe prod- uct that will ultimately be processed for human consumption. Now, a milestone for this year is to complete and achieve Control Union Medical Cannabis Standard certification CUMCS, which will give us a new top level quality position to expand market for more countries whit more exigent quality framework. 

Posted on

Did you already know the components of cannabis CBD, THC AND CBG?

Cannabis or the term marijuana refers to the dried leaves, flowers, stems and seeds of the Cannabis sativa or Cannabis indica plant, it is a plant of the Cannabaceae family and contains more than one hundred biologically active chemical compounds. The most commonly known compounds are delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabigerol (CBG).

Let’s start with CBD: it is the main component of cannabis. It is a non-psychotropic natural compound, with therapeutic and medicinal potential. Its properties and its ability to improve symptoms of various diseases improve the quality of life of many patients. CBD directly activates the serotonin receptor, which gives an anxiolytic effect. In addition, it directly activates several TRPV1 channels, which influence the perception of pain, inflammation, and body temperature. Along with CBD is THC, which is the compound that makes the psychotropic effect of cannabis popular.

Now let’s talk about THC: THC and CBD have the same structure: 21 carbon atoms, 30 hydrogen and two oxygen. But the difference between each is that THC produces the famous psychotropic effect of cannabis. Whereas, CBD does not have these effects.

Δ-9-Tetrahydrocannabinol or THC is the psychotropic component (perception alteration and mood modification) of the cannabis plant that is most important and abundant in varieties classified precisely as psychoactive.

One of the reasons THC has psychotropic effects is because it binds better to cannabinoid receptors. Most of the effects of THC occur in the body’s nervous system.

And finally the CBG: the CBG or the cannabigerol, which is found in 1% within the vast majority of the varieties of the plant. CBG, unlike THC, binds to CBG2 receptors in the digestive system, connective tissue, and the nervous system, moreover, like CBD, CBG does not give a psychotropic effect.

CBG is one of more than 100 known cannabinoids. In fact, it is the first to appear in the plant and, therefore, the rest of the cannabinoids derive from it. As the plant matures, CBGA is converted by plant enzymes into three main cannabinoid precursors: CBG, THC, and CBD.

Like other phytocannabinoids, CBG has a polypharmacological profile that makes it a molecule for medicinal and therapeutic use. These properties derive from its interaction with different receptors present in the cells of the body. Specifically, it interacts with our body through: CB1 and CB2 receptors, TRPV receptors and 5-HT1A receptors.

As with CBD, CBG will be a new alternative in the therapeutic use of cannabis. In addition, some of its medicinal properties are already known, all of them non-psychoactive. For example, its anti-inflammatory power or its effects to alleviate pain.

These are three of the most studied cannabinoids in Cannabis and how they can work in your body if consumed.